The role of pharmacy benefit managers (PBMs) in the drug supply chain and whether "anti-competitive" practices are driving up healthcare costs was scrutinized by the Senate on Thursday.
PBMs are just one player in a "broken supply chain" explained Richard Blumenthal (D-Conn.), during a Thursday hearing of the Senate Subcommittee for the Committee on Commerce, Science, and Transportation.